Zurich Cantonal Bank’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-13,266
| Closed | -$209K | – | 2735 |
|
|
2024
Q1 | $209K | Buy |
13,266
+1,088
| +9% | +$16.7K | ﹤0.01% | 2030 |
|
|
2023
Q4 | $196K | Buy |
12,178
+2,102
| +21% | +$26.8K | ﹤0.01% | 2089 |
|
|
2023
Q3 | $128K | Hold |
10,076
| – | – | ﹤0.01% | 2234 |
|
|
2023
Q2 | $142K | Hold |
10,076
| – | – | ﹤0.01% | 2139 |
|
|
2023
Q1 | $156K | Buy |
10,076
+1,642
| +19% | +$27.4K | ﹤0.01% | 2039 |
|
|
2022
Q4 | $138K | Sell |
8,434
-660
| -7% | -$10.7K | ﹤0.01% | 2059 |
|
|
2022
Q3 | $168K | Hold |
9,094
| – | – | ﹤0.01% | 1854 |
|
|
2022
Q2 | $120K | Hold |
9,094
| – | – | ﹤0.01% | 2122 |
|
|
2022
Q1 | $84K | Sell |
9,094
-4,952
| -35% | -$42.1K | ﹤0.01% | 2354 |
|
|
2021
Q4 | $137K | Buy |
14,046
+10,091
| +255% | +$190K | ﹤0.01% | 2337 |
|
|
2021
Q3 | $134K | Hold |
3,955
| – | – | ﹤0.01% | 2165 |
|
|
2021
Q2 | $145K | Hold |
3,955
| – | – | ﹤0.01% | 2025 |
|
|
2021
Q1 | $177K | Sell |
3,955
-819
| -17% | -$38.1K | ﹤0.01% | 1853 |
|
|
2020
Q4 | $272K | Buy |
4,774
+711
| +17% | +$42.1K | ﹤0.01% | 1647 |
|
|
2020
Q3 | $208K | Hold |
4,063
| – | – | ﹤0.01% | 1559 |
|
|
2020
Q2 | $243K | Buy |
4,063
+2,326
| +134% | +$124K | ﹤0.01% | 1399 |
|
|
2020
Q1 | $72K | Hold |
1,737
| – | – | ﹤0.01% | 1775 |
|
|
2019
Q4 | $108K | Hold |
1,737
| – | – | ﹤0.01% | 1681 |
|
|
2019
Q3 | $59K | Buy |
1,737
+1,074
| +162% | +$31.8K | ﹤0.01% | 1927 |
|
|
2019
Q2 | $15K | Buy |
+663
| New | +$15.5K | ﹤0.01% | 2530 |
|
Other funds holding DCPH
Zurich Cantonal Bank's DCPH Position: Q2 2024 in Review
Zurich Cantonal Bank sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 13,266 shares — an estimated $209K sold.
Zurich Cantonal Bank first reported a position in DCPH in Q2 2019 and held it in 20 quarters. The position peaked at $272K in Q4 2020. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- Zurich Cantonal Bank reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Zurich Cantonal Bank sold 13,266 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $209K.
- Zurich Cantonal Bank first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2019 and held it in 20 quarters.
- Zurich Cantonal Bank's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $272K in Q4 2020.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Zurich Cantonal Bank's 13F filing for Q2 2024, filed 29 Jul 2024.